M&A Deal Summary |
|
|---|---|
| Date | 2006-12-04 |
| Target | St. Francis Medical Technologies |
| Sector | Medical Products |
| Buyer(s) | Kyphon |
| Sellers(s) | EW Healthcare Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 525M USD |
SEARCH BY
Kyphon develops, manufactures and markets minimally invasive medical devices, which employ a proprietary balloon technology, to help surgeons repair spine fractures caused by osteoporosis, cancer and trauma. Kyphon was formed in 1994 and is based in Sunnyvale, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2006 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1985 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 53 |
| Sector: Medical Products M&A | 3 of 24 |
| Type: Add-on Acquisition M&A Deals | 4 of 34 |
| State: California M&A | 3 of 17 |
| Country: United States M&A | 8 of 46 |
| Year: 2006 M&A | 4 of 4 |
| Size (of disclosed) | 4 of 22 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-07-18 |
Confluent Surgical
Waltham, Massachusetts, United States Confluent Surgical, Inc.develops products to address the need for surgical sealing and post-surgical adhesion prevention applications. |
Sell | $245M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-01-01 |
Oraya Therapeutics
Newark, California, United States Oraya Therapeutics is a privately held, development-stage medical technology company, pioneering noninvasive radiation treatments for inflammatory and neovascular diseases of the eye. |
Buy | - |
